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In this paper we report on findings from the first known study using qualitative 
methods to explore factors influencing physicians’ participation in an ongoing 
federally-funded prostate cancer chemoprevention clinical trial. We sought to 
identify ways to improve collaboration between researchers and physicians 
and enhance the success of future projects and employed purposive sampling 
to recruit physician/investigators who were involved or invited to participate 
in the trial. Using the data from open-ended semi-structured interviews, we 
examined patterns in their languaging and created themes. We found that 
individual and structural factors served as barriers and facilitators to 
participation. Willingness and desire to participate in the trial (individual 
factors) were not always enough to result in actual participation due to 
practice environment (structural) constraints. Our research provides a better 
understanding of the complex intersection of factors in this setting and 
through our findings we extend the theory of competing demands into the 
arena of prostate cancer prevention clinical trials, moving the science towards 
solutions to current challenges in recruitment to this type of trial. Keywords: 
Competing Demands, Barriers and Facilitators, Cancer, Screening and 
Prevention, Access to Participants, Open-Ended Semi-Structured Interviews 
  
 I, Dr. Crocker, conducted this research in partial fulfillment of the requirements for 
my doctorate in Applied Anthropology. During my doctoral program, I was uniquely 
situated, also working as a project director for a federally funded, multi-site, prostate cancer 
prevention intervention clinical trial (PCPICT). This resulted in the creation of a liminal 
space, often requiring navigation between the “rules” and languages of two very disparate 
worlds, biomedicine and anthropology, that seemed would never intersect. As the project 
director, I became increasingly aware of the challenges inherent in the design, 
implementation, and daily work of conducting a prostate cancer prevention trial. 
Simultaneously, through the requirements of the doctoral program, I experienced an 
increased skillset in which I acquired new perspectives and an expanded toolkit with which to 
examine the world. The overarching aim of my dissertation research was to show how the 
two worlds could merge, with each informing the other.  
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As project director, I had observed recruitment below goal at most sites participating 
in the PCPICT. Upon review of detailed screening logs, our team was able to delineate 
patient, protocol and infrastructure related barriers that were contributing (Kumar et al., 
2012). Similar challenges to recruitment in chemoprevention clinical trials had been well-
documented by others (Chlebowski, Menon, Chaisanguanthum, & Jackson, 2010; Ruffin & 
Baron, 2000). What we also recognized as an important influence in recruitment was the 
support of committed physicians (Kumar et al., 2012). Referring physicians had been 
recognized in other arenas for the major role they play in getting patients involved in clinical 
trials (Ford et al., 2003; Miller, Crabtree, McDaniel, & Stange, 1998). In fact, physician 
involvement is considered essential for the provision of much of today’s healthcare, and 
physicians serve as a critical link in the chain of events leading to the delivery of  
preventative services including cancer screening (Jaén et al., 2001; Nutting et al., 2001). 
What had not been explored using qualitative methods, and was the driving force behind this 
project was the role of physicians as the “link” to participation in prostate cancer prevention 
intervention trials (as PCPICT gatekeepers).     
Stange and Nutting (1994) used the theory of competing demands to describe the 
multiple factors competing for the provision and delivery of preventative services by primary 
care physicians. The main components (physician, patient, and practice environment) are 
thought to be influenced by factors such as attitudes, knowledge, expectations, practice 
organization, and alternative demands. As a result, the multiple demands of the medical 
encounter compete with those related to prevention during the limited time available. The end 
result is that not all issues receive attention at a specific visit, with preventative services often 
peripheral to other priorities (Stange & Nutting, 1994). Competing demands have also been 
found to vie for physicians’ attention and resources beyond the primary care arena. Joseph 
and Dohan (2009) report a similar influence in recruitment to therapeutic clinical trials. I 
began to wonder what role “competing demands” was playing in referral and recruitment to 
the PCPICT.  
The dearth of literature on the interaction of these demands in the context of a prostate 
cancer prevention intervention clinical trial (PCPICT), a growing area of research with 
unique recruitment challenges, suggested a research gap. I wanted to explore the concept of 
competing demands as a factor influencing physician participation in the PCPICT.  I 
proposed this starting point to explore the individual provider and structural level factors that 
were influencing participation in the PCPICT. This critical first would help to provide an in-
depth understanding of the multitude of factors influencing a physician’s participation. In 
turn, after identification we could focus on solutions.  Therefore, the study objectives were to  
 
a) explore the factors that influence a physician’s participation in the PCPICT 
and  
b) identify ways to improve collaboration between researchers and 
physicians, thus improving the success of future projects.  
 
The research questions were  
 
1) What individual factors influence a physician’s participation in a PCPICT?  
2) What structural factors influence a physician’s participation in a PCPICT? 
3) How do these factors vary depending on the practice site/are (specialty 
centers, academic centers, Veteran’s (VA) medical centers, community 
offices)? 
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The research reported in this paper is a subset of qualitative findings from the larger mixed 
methods study, Physicians as Gatekeepers: Uncovering Barriers and Facilitators to 
Participation in a Prostate Cancer Prevention Intervention Clinical Trial (Crocker, 2013). In 
the larger study I employed an exploratory, mixed methods approach and used open ended 
semi-structured interviews, participant observation, and survey methods to elicit factors 
influencing participation in the PCPICT and identify factors that might be unique to the 
various practice areas. 
I, Dr. Crocker, served as the primary investigator, data collector, and primary analyst. 
The secondary authors served as primary reviewers, guides, mentors, coaches, and 
motivators. The participants were colleagues as well as content experts, considered best 
qualified to help identify solutions. All involved in this project had a vested interest in 
contributing to a reduced burden of cancer. 
 
Methods 
 
Ethics Approval  
 
Prior to subject recruitment, the hospital Scientific Review Committee reviewed and 
approved the research proposal for scientific merit and the University of South Florida 
Institutional Review Board approved it for adherence to Human Subjects Protection.  
 
Recruitment and Description of Participants  
 
To recruit the individuals considered best qualified to provide the desired information 
(Clark & Creswell, 2011), I employed structured purposive sampling. Using a recruitment 
letter, I invited physicians/investigators who were  
 
a) involved or invited to participate in the PCPICT and could provide insight 
into barriers and facilitators to participation;  
b) spoke English;  
c) were willing to provide informed consent and participate in the interview. 
 
Participation was voluntary and there was no incentive provided.  
Twelve physician/investigators were invited to participate and 12 interviews were 
completed (100% response rate). All participants were male. Practice areas as self-reported 
were specialty center (n=5), academic institution (n=2), Veterans Affairs hospital (n=3), 
private practice (n=1), and both academic and private practice (n=1). I assigned pseudonyms 
to ensure the confidentiality of all participants in the following format: interview number-site 
type-participation status (01-S_P). I designated site types as specialty centers (S), academic 
centers (A), VA hospitals (V) or private practice/community (P). Since not all physicians had 
actually referred patients to the PCPICT, they were also delineated as participant (P) or non-
participant (N).   
 
Rationale for Qualitative Design  
 
The project described in this article was aimed at exploring individual provider-level 
factors and structural considerations that influenced the physician/investigator’s participation 
in the ongoing PCPICT. I was also interested in learning how practice area (specialty centers, 
academic centers, Veteran’s [VA] medical centers, community offices) impacted the 
feasibility of participating in the trial. Qualitative inquiry is useful to improve the description 
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and explain complex, real-world phenomenon (Bradley, Curry, & Devers, 2007). It is also  a 
way to engage with others and their practices to better understand a local world (Kleinman & 
Benson, 2006). This allows  for insight into the views and experiences of a specific group 
(Abadie 2010) and contributes to deep knowledge and better awareness within a certain 
context. 
 
Theoretical Frame  
 
 Following an extensive review of the literature, Figure 1 was developed and depicts 
the model of individual and structural factors thought to influence participation in the 
PCPICT. In addition to the review of literature, this adaptation of Stange and Nutting’s 
(1994) Theory of Competing Demands was also based on the lived experience of the 
researchers as we had experienced physician’s participation in the trial to date. As theory is 
modifiable, this was seen as a starting point and framework to guide the research (Bradley, 
Curry, & Devers, 2007). 
 
Figure 1. Proposed Model: Individual and structural factors proposed to influence physician 
participation in the PCPICT 
 
 
• Dark blue boxes represent individual factors believed to impact the 
physician’s participation in cancer prevention intervention clinical trials  
• Light blue boxes represent structural factors believed to impact the 
physician’s participation in cancer prevention intervention clinical trials 
 
Data Collection  
 
I used the model that included only the physician and practice components (not the 
patient), as a guide in the development of the interview guide. I developed the 19 question 
interview guide following an extensive literature review and with specific consideration of 
Theresa Crocker, Karen Besterman-Dahan, David Himmelgreen, Hedie Castañeda, Clement K. Gwede, and Nagi Kumar     5 
the project objectives. This was considered important to obtain a holistic and comprehensive 
understanding of current influences. I also wanted to compare the lived experience of these 
participants with what has been reported previously in other related literature (see Crocker, 
2013) to see if the factors of influence and experiences were similar. Since there were so 
many factors of influence reported in other arenas, the interview guide became quite lengthy. 
I needed a tool to be sure all of the questions ultimately addressed the research questions 
guiding the study. To accomplish this, I created a content matrix (see Appendix) with two 
distinct purposes in mind. Initially I used it to delineate how the various interview questions 
addressed the three research questions. This helped to avoid extraneous questions and assure 
that each research question was addressed. Prior to the initial interview, I pre-tested the guide 
with one researcher and two physicians who were not otherwise involved in the project but 
experienced with clinical trials. These interviews and related discussion took approximately 
90 minutes per person. Following the pre-test I divided some questions into sub questions to 
ease future analysis. The overall content did not change and no substantive revisions or IRB 
review were needed. 
 
Data Management and Quality  
 
Most interviews took 60-90 minutes. The variation between the shortest and longest 
was based on the scope of information and responses shared by the interviewee. With each 
subsequent interview I became more proficient and comfortable navigating the interview 
guide. All research questions were addressed but not necessarily in the same order depending 
on the flow of the exchange which was more conversational and less rote as is common with 
semi-structured interviews compared to structured interviews. Whenever possible, interviews 
were transcribed within 24 hours of completion and prior to completing the next interview. 
Transcriptions were completed in 2 to 3 hours, depending on the length of the interview. I 
reviewed all transcripts for accuracy. Then I used the content matrix for a second purpose—
as a guide to compile and organize responses into the research database. This was an 
organizational scheme to visually link the responses and the research questions. 
To assure consistency in data collection I  
 
a) conducted all of the interviews;  
b) audio-recorded all interviews;  
c) downloaded audio files on a secure, password protected laptop computer 
immediately following all interviews;  
d) transcribed each interview verbatim as quickly as possible following the 
interview;  
e) analyzed the data immediately; and  
f) conducted a thematic analysis.  
 
Data Analysis 
  
I reviewed all 12 transcripts in their entirety for meaningful themes that were useful 
for interpretation. I used an integrated approach to qualitative analysis which allowed for 
application of the principles of inductive reasoning, constant comparison, and the use of 
conceptual and participant perspective codes during analysis (Bradley, Curry, & Devers, 
2007).  For example, when one physician was asked what was important for him when he 
considered participation in the PCPICT and he responded   
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Institutional support. [laugh] It goes back to that. That should be top on the list 
because our mission reads: contribute to the prevention and cure of cancer. So, 
it’s half of our mission. If you look at it from that perspective, half the 
resources should be allocated to that. Or a significant amount of resources 
should be allocated. (03-S_P) 
 
I was able to assign a conceptual code of resources and participant perspective code of 
institutional support. I could also integrate this response and compare it to other respondents’ 
and prior research where organizational or infrastructure factors were also reported as 
influential.  
I conducted analysis concurrently with data collection with the goal of comparing the 
similarities and differences between concepts that emerged in the field, as suggested by 
Glaser and Strauss (1967) and the literature review. I analyzed data from the interviews for 
themes and patterns via analysis of recurring words and phrases to specifically address the 
study objectives and research questions. I also used the constant comparative method to relate 
the views and experiences of respondents from across the various sites to help explain 
important differences and similarities (Barbour, 2001, Glaser & Strauss, 1967). This was 
particularly useful when assessing for variance in structural support at the different types of 
facilities (specialty centers, academic centers, Veteran’s (VA) medical centers, community 
offices). For example, a physician from a specialty center reported, “There is a difference 
between what is expected and the resources provided [to do research].”  Similarly, a 
physician with a private office in the community reported, “If I have to use my infrastructure, 
I don’t have anyone in the office so I have to go through the hospital or I have to hire 
someone. Hiring someone for a small project is not a good idea. You have to have the 
infrastructure.”  
This iterative technique led me in unanticipated directions, at times shaping the 
questions asked and the subsequent data collected. The result is a data set much richer than I 
ever could have anticipated. This benefit was also noted by Charmaz (1990).  
 
Results 
 
As recommended in mixed methods analysis and interpretation (Clark & Creswell, 
2011), data from all sources (interview, observation and survey) were analyzed independently 
and integrated to address the overall study objectives. The results reported in this paper focus 
on the findings from the semi‐structured interviews, related to the theory of competing 
demands as they were reported to influence participation in the PCPICT. These qualitative 
findings are reported thematically, as the individual and structural factors influencing 
participation in the PCPICT that were proposed during study design and confirmed during 
data analysis. This is the first time that I am aware that the theory of competing demands has 
been examined within the context of participation in a PCPICT. In the conclusion, the 
findings from this study are compared to prior research in other areas.  
 
Individual Factors 
 
 In terms of individual provider level factors influencing participation in the PCPICT, 
the majority of participants reported the following as salient in regards to their participation: 
explanatory views on prevention (n=11), notions of risk (n=10) and uncertainty (n=7), and 
influence on the patient-provider relationship (n=8).  
 
 
Theresa Crocker, Karen Besterman-Dahan, David Himmelgreen, Hedie Castañeda, Clement K. Gwede, and Nagi Kumar     7 
Explanatory views on prevention 
 
I asked participants about their general philosophy towards preventive medicine. They 
reported that a personal interest and/or belief in preventive medicine and cancer prevention in 
particular were motivating factors for participation as the following responses suggest, 
“Prevention is very important you know whether it is cancer or . . . infection . . . that’s what 
will cut the health care [cost], it will improve the patient welfare. When you wait for patient 
to be treated, there is nothing without a price” and “. . . prevention of a disease is always a 
more attractive option than trying to treat the disease. I think, yes there is no question, 
prevention is better than therapy.” I noted this across all site types. The physicians also 
reported support of preventive strategies to positively influence their willingness to 
participate in the PCPICT: “I think the willingness to participate in general with the 
practitioners is an understanding of what it means, prevention.”  
 
Notions of risk and uncertainty 
 
I noted risk perception and assessment of risk at two distinct levels, that of the patient 
and that of the provider.  Each served as consideration for participation in the trial. Notions of 
risk from the level of the patient was a means to determine who may be a “good” candidate to 
participate as suggested by one participant:   
 
I think at the end of the day my drive to want to put patients on specific 
chemoprevention trials is believing that they are at increased risk of something  
developing and that ultimately from a biological standpoint [the] 
chemoprevention agent makes biological sense and is being given or 
administered at a time point where  prevention is possible. (01-S_P)   
 
Risk was also reported as influential in reference to physician participation in a trial, “What 
makes or breaks whether a physician will even mention a trial is their interpretation of how 
significant the biopsy findings are.” Uncertainty was seen as inherent to the business of 
science and medicine, and not seen as a deterrent to participation. 
 
[That’s]) why it’s called a trial, we don’t know what is going to happen at all. . 
. .If it works great; if it doesn’t we’re right back in same boat that you were in 
before. As long as [it] doesn’t make it worse, but we’re monitoring it to make 
sure it doesn’t make it worse. (10-A_P) 
 
Influence on the patient-provider relationship 
 
Physicians reported that participation in the PCPICT impacted the physician-patient 
relationship in a positive way: “You get the impression that they have a stronger bond” and 
“One gets attached to patient and patient gets attached to PI. . . . I think it becomes almost 
like [a] family apparatus or relation, which it’s actually very rewarding. Very rewarding.” 
They also reported that participation fostered trust, the sense of a common goal and allowed 
for the provision of involvement at a different and more holistic dimension, allowing for a 
continuum of care even after the study ends: “We do develop a good rapport once being a 
study subject and it carries on after they are off the study.” The factors reported above can be 
characterized as influencing the willingness of the physician/investigators to participate in the 
PCPICT and were reported as likely to be influential when future participation is considered 
as well.  
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Structural Factors 
 
When considering the influence of structural factors on participation in the PCPICT, 
the presence or absence of infrastructural support, broadly described (n=9) and more 
specifically delineated as staffing (n=8) and funding (n=9) were mentioned by the 
participants. They also reported that limitations in time (n=8) were influential.  
 
 Infrastructural support 
 
 Physicians noted an interest in research participation: “There are lots of patients who 
are interested in trials.” However, the importance of infrastructure to support participation in 
these trials was considered necessary: “You have to have the infrastructure, that’s why I think 
the community guys shy away from research, there’s too much paperwork to do.” Though 
recognized as critical to participation, inadequate support was noted across all site types as 
evidenced by the following responses” “(There are) insufficient resources to help 
investigators bring trials to patients and accommodate patients in trials” and   
 
From the organizational level our mandate is to do research. There is a 
difference between what is expected and the resources provided and the 
expectation that we would have to provide the resources and the organization 
somehow is the coordinator of those resources without allocation of resources. 
(03-S_P) 
 
Staffing. More specifically, adequate staffing was recognized as critical, “We need 
more support . . . more clinical trials personnel. . .more coordinators and regulatory [staff]. It 
constrains because we don’t have enough staff. Lack of adequate personnel, it can slow 
things down.” This infrastructural support was necessary to support the work required to meet 
regulatory and other requirements without competing with the needs of non-research patients 
and other responsibilities: 
 
High volume of research patients strains all resources—time, space, 
laboratory, radiological and pharmacy resources. . . .[Research], it’s a side 
kick to the general operation of the hospital. It’s not a research institution. It’s 
accommodated on an individual base based also on available monetary 
resources. (04-V_P)  
 
Funding. Funding is another infrastructural consideration that was reported:  
 
The institution wants money coming in the door. So I think we’re getting away 
from research for the sake of research for sure but looking more at research 
that can pay because if it doesn’t pay it just can’t happen long term. (10-A_P) 
 
This ultimately impacts resource allocation as evidenced by the following responses, 
“[Certain trials] they basically give more money to do it, so sometimes it is easier to find 
those resources that you need to get the job done” and “A non-funded trial gets minimal 
effort from the clinical trials support staff.”  
 
Time. Finally, comments related to time cannot be ignored: “Don’t underestimate 
how busy the doctors are,” as limited time is seen as a constraint to participating in research. 
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“Time definitely. Time dedicated to the encounter . . . sometimes not having adequate support 
staff, clinical trial coordinators who are readily available. . .” “Faculty, they are all incredibly 
stretched thin. I think their limitation is similar to our limitation in terms of time.” This 
impacts participation in the trial:  
 
It’s not that I’m not interested, but I’m pulled in too many directions. We’re a 
real small department and just don’t have that critical mass to do all things we 
need to do and still do a really quality job in clinical research in my book. (07-
P_N)   
 
It also impacts recruitment as well, “It’s got to be a trial that a doctor is willing to remember. 
And then not only willing to remember but willing to spend some of their pressured time to 
bring up in the conversation with the patient.” These structural factors acted as both barriers 
and facilitators in influencing the physician/researcher’s ability to participate in the PCPICT. 
They were also reported as likely to influence participation in future studies.  
By constantly comparing the concepts and themes that emerged in the field (Glaser & 
Strauss, 1967) between participants at the various sites and to prior research findings, I was 
able to conduct an in-depth exploration of individual physician’s experiences and meanings 
related to cancer prevention and participation in cancer prevention intervention clinical trials. 
This also allowed me to consider the larger and unavoidable structural factors that impact the 
practice of medicine and influence participation in such a trial. I found that individual factors 
(such as explanatory views on prevention, notions of risk, and uncertainty and influence on 
the patient-provider relationship), in addition to structural factors (infrastructural support, 
staffing, funding, and time), both which have been identified by other researchers and in 
other contexts, are similarly influential within the realm of a PCPICT. Each served as barriers 
and facilitators to participation in the trial. In-depth exploration resulting from analysis of the 
qualitative data revealed that individual factors seemed to have a greater influence on the 
willingness to participate while structural factors were more likely to impact the ability to 
participate, as Figure 2 depicts. This revised model more clearly depicts the varying influence 
of each factor. The enhanced understanding of how individual and structural factors 
intersected to influence participation in the PCPICT will be useful for the design of future 
trials. 
 
Practice Site/Area Factors    
 
When considering the influence of individual factors on participation in the PCPICT, 
there was homogeneity in responses both within and across types of centers (i.e., specialty, 
academic, Veteran’s Affairs, academic, and private practice). A majority of key informants 
reported factors such as views on prevention, notions of risk, and influence on the patient-
provider relationship as influential.  In regards to structural factors, my analysis of the data 
suggested there was greater heterogeneity in the responses when making comparisons both 
within and across the types of centers. Participants at all site types expressed the critical need 
for research infrastructure. Physicians from all site types noted funding to support research 
efforts and contribute to the institution’s financial goals as relevant. Interestingly, this was 
not a significant barrier within the VA system. Time was seen as both a positive and negative 
influence on participation in the PCPICT. When trial requirements were in-line with or 
conducive to the physician’s usual schema of care for the condition under study, this was 
seen as a positive factor making participation more feasible. However, physicians stated that 
if trial requirements contrasted with usual care, or the time required for documentation 
purposes or to discuss research with a patient resulted in a conflict for a time slot that was 
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previously established for a clinical encounter, it was considered a negative factor of 
influence. Additionally, if the time allotted by administration for research competed with time 
for clinical care, lack of time was considered a significant barrier to participation in research. 
These barriers and facilitators to research participation, particularly the structural factors, 
should be explored in further detail to improve the success of future endeavors. 
Patient population also falls within the realm of structural considerations influencing 
participation, at least in this PCPICT. “Patient” is also the third component noted as 
influential in the theory of competing demands. Considering the scope of practice of each 
participant (ranging from surgical oncology to routine urological care), and the practice 
environment in which their daily work occurs, it is not surprising that there was variation in 
the primary populations seen by each. Analysis revealed that some patients and practice sites 
were considered by the physician/investigators to be better suited for prevention type trials 
than others. This will be elaborated in a forthcoming publication.  
 
Figure 2. Revised Model: Individual and structural factors influencing physician 
participation in the PCPICT 
 
 
 
Discussion 
 
In this paper I report qualitative findings from an ancillary study situated within the 
context of an ongoing PCPICT. The results can be used to inform the design of future trials. 
The findings suggest that individual and structural factors intersect, resulting in competing 
demands that influence the willingness and ability of physician/investigators to participate or 
refer patients for participation in the PCPICT. Individual factors such as explanatory views 
on prevention, notions of risk and uncertainty and influence on the patient-provider 
relationship appear to have a greater influence on the willingness of physicians to participate 
in a PCPICT. Structural factors such as staffing, access to resources, time and a patient 
population with the necessary diagnosis, many which are often beyond the 
physician/investigator’s control, are more influential in regards to the ability to participate. 
Similar to research conducted in other contexts (Klabunde et al., 2011), features of the 
various practice environments influenced involvement in the PCPICT, serving as both 
barriers and facilitators to participation.  
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I used the theory of competing demands to frame this research, drawing on micro and 
macro level factors of influence reported in other contexts to provide a more holistic 
understanding of the multitude of variables influencing participation in the PCPICT. This 
research expands the concept of competing demands from the primary care setting to the 
realm of cancer prevention intervention clinical trials. Factors identified as influential to the 
provision of preventative service such as the physician, practice environment, patient, 
attitudes, expectations and alternative demands (Jaén et al., 2001; Nutting et al., 2001) are 
similarly influential in the context of a  PCPICT. Physician willingness and desire to 
participate was not always enough to result in actual participation. Notably, the ability to 
participate was influenced by constraints within the practice environment such as competing 
demands for time, space, and personnel as well as the patient population.  
 
Limitations and Future Directions 
 
I acknowledge benefits as well as potential concerns related to familiarity of the 
researcher in the research setting (DiCicco-Bloom & Crabtree, 2006; Hanson, 1994; Preston, 
1997). With this project, it was beneficial to be able to provide firsthand knowledge of the 
challenges of an ongoing project and allowing for a research design that provided a broader 
and more holistic examination of the issues. It also afforded direct access to the 
physician/investigators who were willing to participate. The potential for bias in participant 
response and during data collection and analysis due to the fact that all interviewees had a 
previously established working relationship with me must be acknowledged. Reflexivity 
(Hahn & Kleinman, 1983) on my part helped to minimize any constraints or potential bias 
related to working in a familiar setting. Due to the specific nature of this project and the 
history of involvement, this sample was considered best qualified to address the research 
questions. The association positively influenced the willingness of the key informants to 
participate, as evidenced by the 100% participation rate.  
Though triangulation of the data from all sources helped to corroborate the findings of 
the larger project, cross-checking for intercoder agreement would have additionally 
strengthened the interpretation of the qualitative portion of this exploratory study. The 
capacity to do so was limited by the resources available as this research was for a doctoral 
dissertation; however, since this was a study where I was embedded in ongoing relationships 
with the research participants, some have suggested that a single researcher is sufficient and 
preferred (Bradley, Curry, & Devers, 2007). This research focused on one very specific 
context-prostate cancer prevention intervention clinical trials- and was aimed at describing 
the physician’s role as gatekeeper within this setting. My goal was to provide greater 
understanding of a specific lived reality and make recommendations for future research. It is 
recognized that due to the small sample size and specific context under analysis, results might 
not be generalizable to other research situations beyond the realm of PCPICTs. Expanding 
the study to a larger subset would be important to increase the strength of the conclusions 
beyond this setting. The findings reflect the perspective of only those who met the inclusion 
criteria. Some insight into possible reasons for non-participation in the PCPICT can be 
gleaned from the responses provided by those who were interviewed; however, their 
responses should not be considered reflective of the opinions of all non-participants. 
Soliciting this voice is important for the success of future prostate cancer prevention research 
projects. A consideration of the competing demands and intersection of factors within each 
local environment is encouraged. Additionally, the voice of the female physician is absent as 
all physician/investigators in the PCPICT were male.   
This research did not examine how physician willingness and ability ultimately 
influenced actual recruitment to the PCPICT as compared to the project recruitment goals. 
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This would be a valuable next step, adding overall insight to better understanding the 
challenge of recruitment to prevention clinical trials within each of the four contexts. 
Additional examination could also delineate the relative influence of factors such as medical 
specialty, country of primary medical training, career stage, practice model, type of funding 
and internal research priorities, all which emerged as factors influencing participation in the 
PCPICT, via the various modes of data collection. Further exploration to more clearly 
describe the barriers and facilitators to participation among physician/investigators at all site 
types would help to minimize the influence of competing demands in future prevention trials. 
Finally, as previously noted, a discussion of competing demands typically includes the 
interaction of the physician, the patient, and the practice environment (Stange & Nutting, 
1994). This project includes an exploration of only two of these components, the physician 
and practice environment. Though data emerged that can be associated with the patient 
component, additional research that captures the patient perspective as well as the experience 
of other members of the clinical research team would help to provide a more comprehensive 
understanding of all of the relevant issues influencing patient recruitment in this and other 
cancer prevention clinical trials.  
 
Table 1. Summary of considerations for future studies 
Key features Explanation 
Scientific Rationale Future studies must make biological sense and be for a condition 
where the scientific rationale is clear and no ambiguity 
regarding the significance of treatment exists 
Minimal burden Protocol requirements must be closely in line with usual practice 
for the condition under study to minimize patient and physician 
burden 
Dedicated staff Dedicated research time and personnel is highly desirable 
Partnerships/Collaboration Partnerships with “friendly” community physicians must be 
forged to extend availability to a wider range of patients 
 A collaborative project, available at the site of usual care 
delivery when possible with the urologist remaining key 
decision maker (in partnership with patient and research team) is 
highly desirable 
Cost neutral Trial must utilize existing resources or provide for additional so 
that the venture is at least cost neutral for the institutions 
involved 
 
Conclusion 
 
My results reveal that biomedical factors such as risk perception and scientific 
rationale in addition to social factors such as explanatory views on prevention, concerns for 
their patient’s well-being, and prior personal and professional experiences were salient and 
influential to participation in the PCPICT. As with prior research (Jaén et al., 2001; Joseph & 
Dohan, 2009; Nutting et al., 2001; Stange & Nutting, 1994), the intersection of these 
individual, social, biomedical, and structural factors influenced not only the willingness but 
the ability of physician/investigators, creating barriers as well as facilitators to participation 
in the PCPICT. These findings suggest that factors previously shown to influence 
participation in therapeutic clinical trials (Crosson, Eisner, Brown, & Maat, 2001) and cancer 
prevention trials (Hall et al., 2010) are similarly influential in the realm of a prostate cancer 
prevention intervention trial. The results of this study, allow for a better understanding of the 
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intersection of these factors within this particular context.  A summary of main points, from 
the perspective of the key informants and to maximize the success of future studies is 
provided in Table 1.   
This research contributes a qualitative component to an ongoing clinical trial, and 
expands the theory of competing demands into the arena of prostate cancer prevention 
clinical trials. Additionally, these findings move the science towards solutions to the current 
challenges in recruitment to this type of trial. I hope that the results will inform design, 
funding and implementation of future prevention clinical trials.  
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Appendix  
Content Matrix with Research Questions and Examples Questions from Interview Guide 
 
Research question 1: What individual factors influence a physician’s participation in a 
PCPICT?  
 
Interview question 9: 
 
What factors are most important to you, when considering whether or not to participate 
in a cancer prevention intervention clinical trial?   
[probe: personal interest, participation in the trial design, authorship, meeting the needs 
of the community that you serve, other] 
 
Interview question 13:  
 
How does your philosophy towards preventive medicine influence your willingness to 
participate in a cancer prevention intervention trial? 
 
Interview question 14:  
 
Tell me about how participation in a cancer prevention trial impacts the physician-
patient relationship? [probe: neutral, positive or negative?] 
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Interview question 15:   
 
Thinking back to times when you have decided to offer participation in a clinical trial, 
  
a) How has the possibility of uncertainty in the plan of care associated with 
participation in the trial played a role in your decision to offer the trial? If 
so, can you tell me more about this?  
b) How has the possibility of uncertainty in the outcome associated with 
participation in the trial, played a role in your decision to offer the trial? 
Can you tell me more about this? 
 
Interview question 17: 
 
Prior research suggests a possible conflict when a provider plays the dual role of 
advocate for the patient and for the research.   
 
a) Have you ever experienced this?   
b) Can you tell me about what changes when patient becomes research 
participant?  
c) Can you tell me about what changes when the study is done and the 
research participant becomes the patient again? 
 
Research Question 2: What structural factors influence a physician’s participation in a 
PCPICT? 
 
Interview question 7: 
 
a) Is there any concern of financial loss if patients move care to participate in 
a prevention, intervention trial?  
b) How salient is this concern? 
c) Are there ways this can be mediated so that more people can be involved 
in cancer prevention trials?  
 
Interview question 8:   
 
From the perspective of your institution, what would help to increase the likelihood of 
participation in cancer prevention clinical trials in the future? [probe: compensation, 
protected time, staff training or dedicated study staff, less paperwork, simplified 
approval process, personal interest in the trial] 
 
Interview question 11:  
 
From your perspective, what would help to increase the likelihood of participation in 
cancer prevention clinical trials in the future?  
[probe: compensation, protected time, staff training or dedicated study staff, less 
paperwork, simplified approval process, personal interest in the trial] 
 
Research Question 3: How do these factors vary depending on the practice site/area    
(specialty centers, academic center, VA medical centers, community offices)?   
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          Interview question 1: 
           
a) Can you tell me a little about the organization that you work for?    
b) Can you tell me about how the organizational infrastructure facilitates 
participation in research/clinical trials?   
c) Can you tell me about how the organizational infrastructure constrains 
participation in research/clinical trials?   
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